Pharmaceutical Research and Manufacturers of America
E555145
Pharmaceutical Research and Manufacturers of America is a major U.S. trade association representing leading biopharmaceutical and drug research companies.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Pharmaceutical Research and Manufacturers of America canonical | 1 |
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
industry group
ⓘ
nonprofit organization ⓘ trade association ⓘ |
| abbreviation | PhRMA NERFINISHED ⓘ |
| activity |
coalition building with patient and provider groups
ⓘ
lobbying the U.S. Congress ⓘ lobbying the executive branch of the U.S. government ⓘ policy research and analysis ⓘ public relations campaigns ⓘ publishing reports on drug development ⓘ |
| collaboratesWith |
National Institutes of Health
NERFINISHED
ⓘ
U.S. Food and Drug Administration NERFINISHED ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| fieldOfWork |
biomedical research policy
ⓘ
drug pricing policy ⓘ health policy ⓘ intellectual property policy ⓘ pharmaceutical regulation ⓘ |
| focus |
brand-name prescription drugs
ⓘ
innovative medicines ⓘ research and development investment ⓘ |
| hasMember |
AbbVie
NERFINISHED
ⓘ
Amgen NERFINISHED ⓘ Bristol Myers Squibb NERFINISHED ⓘ Eli Lilly and Company NERFINISHED ⓘ Gilead Sciences NERFINISHED ⓘ Johnson & Johnson NERFINISHED ⓘ Merck & Co. NERFINISHED ⓘ Novartis NERFINISHED ⓘ Pfizer NERFINISHED ⓘ Roche NERFINISHED ⓘ |
| headquartersLocation | Washington, D.C. ⓘ |
| industry |
biopharmaceutical industry
ⓘ
drug research and development ⓘ pharmaceutical industry ⓘ |
| purpose |
advocacy for member pharmaceutical companies
ⓘ
influence health care legislation ⓘ promote policies favorable to drug innovation ⓘ represent pharmaceutical industry interests before government ⓘ |
| regionServed |
United States of America
ⓘ
surface form:
United States
|
| represents |
biopharmaceutical companies
ⓘ
innovative drug manufacturers ⓘ research-based pharmaceutical companies ⓘ |
| scope | national ⓘ |
| subjectOf |
criticism over influence on health policy
ⓘ
debates on drug pricing ⓘ |
| website | https://www.phrma.org ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.